Status | Study |
Not yet recruiting |
Study Name: Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella Condition: Rubella Measles Date: 2017-05-09 Interventions: Biological: Measles and Rubella vaccine |
Not yet recruiting |
Study Name: Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age Condition: Measles Rubella Date: 2017-02-21 Interventions: Biological: Measles-rubella (MR) vaccine at 6 and 9 months |
Completed |
Study Name: Study of Rubella Immunity. Response to Vaccination of Subjects With Very Low, Equivocal or Undetectable Titers of Rubella Virus Antibodies Condition: Pregnancy Date: 2016-10-13 Interventions: Biological: Determination of Anti-Rubella Antibody, E1 |
Completed |
Study Name: Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Condition: Rubella Measles Date: 2014-07-16 Interventions: Biological: Double viral (MR) vaccine Measles and Rubella vaccine, as single arm |
Completed |
Study Name: Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age Condition: Measles; Mumps; Rubella Date: 2014-07-03 Interventions: Biological: GSK Biologicals measles, mumps and rubella vaccine live (GSK 209 |
Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Specified Drug-use Survey of Vaccinees After the Second Vaccination Condition: Measles/Rubella Date: 2014-06-04 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
Completed |
Study Name: Freeze-dried Live Attenuated Measles/Rubella Combined Vaccine (Schwarz FF-8 Strain/TO-336 Strain) Special Drug Use Surveillance of Vaccinees After the First Vaccination Condition: Measles/Rubella Date: 2014-05-28 Interventions: Drug: Freeze-dried live attenuated measles and rubella combined vaccine (Schwarz FF-8 strain/TO-336 strain) |
Completed |
Study Name: Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older Condition: Rubella Mumps Measles Date: 2014-02-06 Interventions: Biological: Priorix® 1 do |
Completed |
Study Name: Study of Immunogenicity, Reactogenicity and Safety of the Combined Measles, Mumps and Rubella Vaccine Produced by Bio-Manguinhos/Fiocruz in Children 12-15 Months of Age, Followed by Tetraviral Vaccine in Children 15-18 Months. Condition: Measles Mumps Rubella Date: 2013-11-08 Interventions: Biological: MMR Bio-Manguinhos |
Completed |
Study Name: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella) Condition: Mumps Rubella Measles Date: 2013-06-07 Interventions: Biological: MMR (Mumps, Measles and Rubella) MMR (Mumps, Measles and Rubella) |